Highbridge Capital Management »

Theseus Pharmaceuticals shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Theseus Pharmaceuticals shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Theseus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Theseus Pharmaceuticals held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theseus Pharmaceuticals by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5B 617k 4050.00

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Occidental Pete Corp Warrant (Principal) (OXY.WS)
Ford Mtr Co Del Bond (Principal)
Occidental Pete Corp Option Put Option
Liberty Broadband Corp Common (LBRDK)
Nice Bond (Principal)
Gamida Cell Bond (Principal)
Sarepta Therapeutics Bond (Principal)
Integra Lifesciences Hldgs C Bond (Principal)
Pdd Holdings Bond (Principal)
American Airlines Group Bond (Principal)
Lci Inds Bond (Principal)
Tilray Brands Bond (Principal)
Omnicell Bond (Principal)
Sea Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Theseus Pharmaceuticals

OrbiMed Advisors
Tang Capital Management
Frazier Life Sciences Management
Vanguard Group
Omega Fund Management
Lynx1 Capital Management
Highbridge Capital Management
Beryl Capital Management
MMCAP International Inc. SPC
ADAR1 Capital Management
Laurion Capital Management
Citadel Advisors
Charles Schwab Investment Management
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Dimensional Fund Advisors

View all funds holding Theseus Pharmaceuticals